New diabetes saliva-based diagnostic test in the works
HOUSTON A new saliva-based test for the identification and diagnosis of diabetes is under development, the American Association of Clinical Endocrinologists announced Tuesday.
Research promoting a painless new method for detecting diabetes, utilizing saliva, will be presented May 15, at the AACE’s 18th Annual Meeting & Clinical Congress in Houston.
While searching for biomarkers that may indicate diabetes, doctors examined the saliva of 40 patients. Through salivary analysis, they managed to devise a new “non-invasive” method for detecting diabetes that foregoes the uncomfortable prick of a needle — patients need only to spit into a cup. The spit test could be performed for little cost in a doctor’s office or at a patient’s home.
“Our goal was to characterize proteins in human saliva that may indicate prediabetes and Type-2,” stated Srinivasa Nagalla, a member of the research team. “Analysis of these proteins allowed us to develop a new method for screening, detecting and monitoring the diabetic state.”
NCPA, Roche Diagnostic team up with new online diabetic resource
ALEXANDRIA, Va. In an alliance with Roche Diagnostic, the National Community Pharmacists Association is giving its independent pharmacy members a new tool to expand their presence in the crucial market for diabetic care services and supplies.
NCPA has launched a new, online resource, dubbed the “Diabetes Supply Center,” through the organization’s Pharmacist e-Link. The Web site is designed to provide pharmacists with the information needed to serve patients with diabetes more effectively and make diabetic supplies a viable part of their business, according to the group.
The site helps pharmacists navigate the regulatory process for competitive bidding, accreditation or surety bonds, NCPA noted Monday. It also provides business tools, articles catering to pharmacists, news updates, expert opinion forums and a regular newsletter.
“Many independent community pharmacies are caught between the need to serve their patients with diabetes and navigating an excessive amount of government regulation and costs if they want to continue selling medical supplies such as diabetes testing strips,” said NCPA president Holly Whitcomb Henry. “NCPA is proud to partner with Roche Diagnostic to help community pharmacies better confront all of these challenges through the wide array of information found at the Diabetes Supply Center on Pharmacist e-Link.”
Added Luc Vierstraete, Head of Roche Diagnostic Care North America, ““The role of pharmacists continues to grow and evolve and Roche recognizes their important role in the health care community.”
An American Diabetes Association study in 2007 found 17.5 million people diagnosed with diabetes in America at a cost of $174 billion. The average patient spends approximately $2,500 at community pharmacies for diabetes medications and supplies.
Pure Biosciences’ SDC-based disinfectants meet CDC standards for swine flu care
SAN DIEGO Pure Bioscience on Sunday confirmed that all EPA-registered SDC-based disinfectants, branded Axen30, meet the recommendations by the United States Centers for Disease Control for infection control for care of patients with confirmed or swine flu in both home and healthcare settings.
“Pure’s SDC-based disinfectant is effective against both human and avian influenza A, and our distributors across the nation are poised and ready to respond to the current outbreak,” stated Pure president and CEO Michael Krall. “Should the current outbreak become pandemic, Pure has the manufacturing capability to react not only to the needs in the U.S. but also abroad to supply our powerful disinfectant to governments, healthcare institutions and consumers seeking to effectively stem the spread of swine flu.”
Axen30 is sold through a variety of distributors under more than a dozen private label brands, the company stated. Pure’s SDC-based disinfectants have been registered by the EPA specifically for use on children’s toys, cribs, high chairs and other sensitive areas of the home as well as for use on hard surfaces in multitudes of environments, including hospitals, schools and offices.
Guidance published by the CDC on April 24 for infection control in healthcare settings advises that “disinfection strategies used during influenza seasons can be applied to the environmental management of swine influenza.” Additional guidance published on April 25 for infection control in the home recommends keeping “surfaces (especially bedside tables, surfaces in the bathroom, and toys for children) clean by wiping them down with a household disinfectant according to directions on the product label.”